polymyxin B derivatives (The Medicines Company/Monash University)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepolymyxin B derivatives (The Medicines Company/Monash University)
Drug Alias NameFADDI-287
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial cell wall synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsCarbapenem-Resistant InfectionBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMonash University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMonash UniversityThe Medicines Company
Active IndicationsN/A
Inactive IndicationsCarbapenem-Resistant InfectionBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A